NCT00872495Recruiting
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 27 Mar 2009
- Start date
- Sept 2002
- Primary completion date
- Oct 2028
- Lead sponsor
- Lahey Clinic
- Diseases
- Bladder cancer
- NCT number
- NCT00872495
What you commit to
- Study type: Observational
- Planned participants: 500
- From Sept 2002 to the primary completion date, Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \< than 18 years of age
Who the study is looking for
- Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up)
- Control Group: No known evidence of bladder cancer-one urine sample
- \> than 18 years of age
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lahey Clinic, Inc Coordinator of this site? Confirm its status | Burlington | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.